The use of Aquaphor to prevent transepidermal water loss and to maintain electrolyte balance in preterm newborn infants in the first week of life.

ISRCTN ISRCTN89579779
DOI https://doi.org/10.1186/ISRCTN89579779
Protocol serial number N0060131640
Sponsor Department of Health
Funder Chelsea and Westminster Healthcare NHS Trust (UK)
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
10/03/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Neonatal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Enitan M Ogundipe
Scientific

Neonatal Unit
Chelsea & Westminster Hospital
369 Fulham Road
London
SW10 9NH
United Kingdom

Phone +44 (0)20 8746 7881
Email enitan.ogundipe@chelwest.nhs.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesWill the use of an emollient (aquaphor) in the first week of life reduce transepidermal water loss (TEWL) in very preterm babies and improve their metabolic and electrolyte balance compared to infants not given the emollient treatment ?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedNeonatal Diseases: Transepidermal water loss (TEWL)
InterventionStandard care compared with emollient (aquaphor) therapy in addition to standard care.
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)aquaphor
Primary outcome measure(s)

1. Fluid requirement in 1st week of life
2. Neonatal morbidity: electrolyte balance, metabolic balance, chronic lung disease, treated patent ductus arteriosus

Key secondary outcome measure(s)

Not provided at time of registration

Completion date31/12/2007

Eligibility

Participant type(s)Patient
Age groupNeonate
SexNot Specified
Target sample size at registration88
Key inclusion criteriaNot provided at time of registration
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/11/2003
Date of final enrolment31/12/2007

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Neonatal Unit
London
SW10 9NH
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Abstract results results No No